RecruitingPhase 3NCT06982521
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
Sponsor: Relay Therapeutics, Inc.
Longmont, CO · +51 more sites
4 recruiting breast cancer studies with a site in Longmont, CO.
Sponsor: Relay Therapeutics, Inc.
Longmont, CO · +51 more sites
Sponsor: NRG Oncology
Aurora, CO · Colorado Springs, CO · +1223 more sites
Sponsor: NRG Oncology
Aurora, CO · Boulder, CO · Colorado Springs, CO · +809 more sites
Sponsor: SWOG Cancer Research Network
Aurora, CO · Boulder, CO · +952 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.